Citadel Advisors
AGL icon

Citadel Advisors’s Agilon Health AGL Stock Holding History

Citadel Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-724
Closed -$12.5K – 12883
2025
Q4 		$12.5K Sell
724
-4,988
-87% -$96.7K ﹤0.01% 12415
2025
Q3 		$147K Sell
5,712
-1,168
-17% -$44.1K ﹤0.01% 11546
2025
Q2 		$396K Sell
6,880
-416
-6% -$33.4K ﹤0.01% 9172
2025
Q1 		$790K Buy
7,296
+4,960
+212% +$432K ﹤0.01% 7474
2024
Q4 		$111K Sell
2,336
-3,656
-61% -$221K ﹤0.01% 11325
2024
Q3 		$589K Buy
5,992
+4,324
+259% +$558K ﹤0.01% 7920
2024
Q2 		$273K Buy
1,668
+404
+32% +$57.6K ﹤0.01% 9323
2024
Q1 		$193K Sell
1,264
-2,112
-63% -$351K ﹤0.01% 10378
2023
Q4 		$1.06M Buy
3,376
+2,744
+434% +$993K ﹤0.01% 6552
2023
Q3 		$281K Sell
632
-24
-4% -$10.8K ﹤0.01% 9297
2023
Q2 		$284K Sell
656
-1,316
-67% -$740K ﹤0.01% 9171
2023
Q1 		$1.17M Buy
1,972
+1,184
+150% +$663K ﹤0.01% 6435
2022
Q4 		$318K Sell
788
-12
-2% -$5.63K ﹤0.01% 9191
2022
Q3 		$468K Sell
800
-1,348
-63% -$807K ﹤0.01% 8604
2022
Q2 		$1.17M Buy
2,148
+1,804
+524% +$912K ﹤0.01% 6664
2022
Q1 		$218K Buy
344
+28
+9% +$14.4K ﹤0.01% 11311
2021
Q4 		$213K Sell
316
-300
-49% -$183K ﹤0.01% 11718
2021
Q3 		$404K Buy
+616
New +$526K ﹤0.01% 10385

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors's AGL Position: Q1 2026 in Review

Citadel Advisors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 49,603 shares — an estimated $802K sold.

Citadel Advisors first reported a position in AGL in Q2 2021 and held it in 16 quarters. The position peaked at $35.1M in Q2 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Citadel Advisors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 49,603 Agilon Health shares in Q1 2026, an estimated $802K.
  • Citadel Advisors first reported a position in Agilon Health in Q2 2021 and held it in 16 quarters.
  • Citadel Advisors's Agilon Health position peaked at $35.1M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.